squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology#195336ClinicalTrials.gov
• LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer#876062ClinicalTrials.gov
• A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer#160362ClinicalTrials.gov
• De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma#864341ClinicalTrials.gov
• Title XELOX FOR SALIVARY GLAND CANCERS#871183ClinicalTrials.gov
• A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC#889697ClinicalTrials.gov
• GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy#836993ClinicalTrials.gov
• Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer#872642ClinicalTrials.gov
• PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy#67809ClinicalTrials.gov
• A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.#828040ClinicalTrials.gov
• Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner#432900ClinicalTrials.gov
• Enhanced CT‑based radiomics model to predict CD40LG expression and clinical prognosis in head and neck squamous cell carcinoma.#122807NCBI PubMed Central
• Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1#146480ClinicalTrials.gov
• IGF2BP3 Promotes Head and Neck Squamous Cell Carcinoma Progression via the M6A-LDHA-Lactate-H4K8la Axis and E2F2 Activation.#148348NCBI PubMed Central
• Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC#172313ClinicalTrials.gov
• Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.#201797ClinicalTrials.gov
• Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection#311124ClinicalTrials.gov
• Heterogeneity and plasticity of tumor-associated macrophages in oral squamous cell carcinoma: implications for diagnosis and tumor microenvironment characterization.#399734NCBI PubMed Central
• Camrelizumab plus nimotuzumab as second-line therapy for advanced esophageal squamous cell carcinoma: a multicenter phase II study#784043Deutsche Nationalbibliothek
• Phase II Study of RAD001 Head and Neck Cancer#800399ClinicalTrials.gov
• Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC#881485ClinicalTrials.gov
• Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)#899421ClinicalTrials.gov
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin#833661ClinicalTrials.gov
• Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma#252976ClinicalTrials.gov
• A multi-omics integration of bulk and single-cell transcriptomics identifies and validates a 16-gene epithelial-mesenchymal transition prognostic signature in tongue squamous cell carcinoma.#452947NCBI PubMed Central
• Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies#803666ClinicalTrials.gov
• Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer#28329ClinicalTrials.gov
• Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)#889270ClinicalTrials.gov
• Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy#414476ClinicalTrials.gov
• Study of ADCT-301 in Patients With Selected Advanced Solid Tumors#814039ClinicalTrials.gov
• Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer#853243ClinicalTrials.gov
• A Phase 1 of CTX-8371 in Patients With Advanced Malignancies#804246ClinicalTrials.gov
• Digital Phenotyping of Psychological Distress in Skin Cancer Patients#805545ClinicalTrials.gov
• Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.#850352ClinicalTrials.gov
• Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN#172292ClinicalTrials.gov
• Diagnostic performance of convolutional neural network-based AI in detecting oral squamous cell carcinoma: a systematic review and meta-analysis.#221190NCBI PubMed Central
• Beyond Binary Positivity: Spectrum of Nodal Tumor Burden in Sentinel Lymph Node Biopsy for High-Risk Cutaneous Squamous Cell Carcinoma.#236168NCBI PubMed Central
• Management of oropharyngeal squamous cell carcinoma: 2025 update#330211HAL (France)
• ORC6 marks a replication-active malignant epithelial state and is associated with immune-low features in oral squamous cell carcinoma.#430799NCBI PubMed Central
• Advocating for Precision Neoadjuvant and Subsequent Adjuvant Therapies in Esophageal Squamous Cell Carcinoma: Evidence From a Real-World Multicenter Study.#457436NCBI PubMed Central
• A Multimodal Graph Neural Network Based on MRI Radi-omics for Prognostic Prediction in Locally Advanced Cervical Squamous Cell Carcinoma.#480906NCBI PubMed Central
• Lesion-specific oral microbiome signatures and predicted carcinogenic pathways in oral squamous cell carcinoma: a paired-site study in Pakistan.#653358NCBI PubMed Central
• Vaccination With Flt3L, Radiation, and Poly-ICLC#683112ClinicalTrials.gov
• Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck#838378ClinicalTrials.gov
• Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study)#850320ClinicalTrials.gov
• The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy#852188ClinicalTrials.gov
• Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer#860239ClinicalTrials.gov
• Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown Primary#868604ClinicalTrials.gov
• SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCC#885294ClinicalTrials.gov
• A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab#899340ClinicalTrials.gov